• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Predictive Value of Cytokine/Chemokine Responses for the Disease Severity and Management in Children and Adult Cases with COVID-19

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Nov 23.
doi: 10.1002/jmv.26683. Online ahead of print.
Predictive Value of Cytokine/Chemokine Responses for the Disease Severity and Management in Children and Adult Cases with COVID-19


Yasemin Ozsurekci[SUP] 1 [/SUP], Kubra Aykac[SUP] 2 [/SUP], Ahmet Gorkem Er[SUP] 3 [/SUP], Burcin Halacli[SUP] 4 [/SUP], Mehmet Arasli[SUP] 5 [/SUP], Pembe Derin Oygar[SUP] 1 [/SUP], Sibel G?rlevik[SUP] 1 [/SUP], Burcu Ceylan Cura Yayla[SUP] 2 [/SUP], Jale Karakaya[SUP] 6 [/SUP], Alparslan Alp[SUP] 7 [/SUP], Arzu Topeli[SUP] 4 [/SUP], Ali B?lent Cengiz[SUP] 1 [/SUP], Murat Akova[SUP] 3 [/SUP], Mehmet Ceyhan[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The disease course of children with COVID-19 seems milder as compared with adults, however, actual reason of the pathogenesis still remains unclear. There is a growing interest on possible relationship between pathogenicity or disease severity and biomarkers including cytokines/chemokines.
Objectives: We wondered whether these biomarkers could be used for the prediction of the prognosis of COVID-19 and improving our understanding on the variations between pediatric and adult cases with COVID-19.
Study design: The acute phase serum levels of 25 cytokines and chemokines in the serum samples from 60 COVID-19 pediatric (n=30) and adult cases (n=30) including 20 severe/critically ill, 25 moderate and 15 mild patients and 30 healthy pediatric (n=15) and adult (n=15) volunteers were measured using commercially available fluorescent bead immunoassay and analyzed in combination with clinical data.
Results: Interferon gamma-induced protein 10 (IP-10) and macrophage inflammatory protein (MIP)-3β levels were significantly higher in patient cohort including pediatric and adult cases with COVID-19 when compared with all healthy volunteers (p= <0.001 in each) and whereas IP-10 levels were significantly higher in both pediatric and adult cases with severe disease course, MIP-3β were significantly lower in healthy controls. Additionally, IP-10 is an independent predictor for disease severity, particularly in children and IL-6 seems a relatively good predictor for disease severity in adults.
Conclusion: IP-10 and MIP-3β seem good research candidates to understand severity of COVID-19 in both pediatric and adult population and to investigate possible pathophysiological mechanism of COVID-19. This article is protected by copyright. All rights reserved.

Keywords: coronavirus; critically ill patient; pediatrics; treatment.
 
Back
Top Bottom